Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 11

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 11
---
 be issued shall be entitled to dividends as of the date of registration of the capital increase in the Commercial Register. (vi)Type of contribution: Contribution in kind: [•] Kadimastem Ordinary Shares. (vii) Transfer restrictions regarding the new registered shares: none. (viii) Restriction or cancellation of subscription rights and the consequences of subscription rights not exercised or withdrawn: The subscription rights of all shareholders in respect of this capital increase are cancelled because the new shares will be used for the settlement of the acquisition of all Kadimastem Ordinary Shares under the Merger Agreement and the newly issued NLS Common Shares will be allocated to the (then former) shareholders of Kadimastem. Following the resolution of the extraordinary shareholders’ meeting on the ordinary capital increase, the extraordinary shareholders’ meeting shall briefly be paused in order for the ordinary capital increase to be implemented. Following this implementation, the extraordinary shareholders’ meeting shall be resumed and shall vote on the following agenda items. 3. Ordinary Share Capital Increase by Issuing Preferred Shares Explanation:The Company entered into a securities purchase agreement dated December 4, 2024 (the “PIPE SPA”), with a certain accredited investor. Pursuant to the terms of the PIPE SPA, the Company has agreed to obtain shareholder approval to authorize 10,000,000 Preferred Shares for the purpose of allowing the investor in the PIPE SPA to elect to receive Preferred Shares under the PIPE SPA. Proposal:The Board of Directors proposes that the Company’s share capital shall be increased by means of an ordinary capital increase as follows: (i)Nominal amount by which the share capital is to be increased: a maximum of CHF [•]. (ii)Amount of contributions to be made thereon: 100% of the nominal value (fully paid -up). (iii)The number, par value and type of newly issued shares as well as any preferential rights attached to individual classes of shares: a maximum of [•] registered Preferred Shares, with a nominal CHF 0.03 each, and privileges as per the Articles. (iv)Issue price: The Board of Directors is authorized to determine the issue price. (v)Time of dividend entitlement: The new registered preferred shares to be issued shall be entitled to dividends as of the date of registration of the capital increase in the Commercial Register. (vi) Type of contribution: The issue price will be paid in cash. (vii) Transfer restrictions regarding the new registered shares: none. (viii) Restriction or cancellation